RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.


Founded in 2011, RxSight is a medical device and digital imaging company focused on providing innovative solutions to improve visual outcomes and quality of life for individuals living with vision-limiting eye conditions. We develop, market, and distribute a comprehensive suite of digital imaging products, and we are dedicated to improving and enhancing mission critical technologies for the visibility of retinal structures, helping physicians provide advanced levels of vision care.

RxSight strives to provide superior products and services to enable healthcare providers to improve patient care.

RxSight’s goal is to be a leader in retinal imaging, pioneering revolutionary products and applications that set the gold standard of care.

Key Team

Mr. Eric J. Weinberg (Chief Commercial Officer)

Rebecca Williston (VP of Accounting & Fin.)

Mr. Matt Haller Ph.D. (Chief Technology Officer)

Steve Everly (VP of US Sales)

Mr. Roy Freeman (VP of Marketing)

Caroline Vaughn (VP of HR)

Scott Gaines (Sr. VP of Commercial Operations & Bus. Process)

Recognition and Awards
RxSight has been the recipient of numerous awards, including The MDDI Medical Technology Entrepreneur Award, The MIT Inclusive Innovation Prize and The Red Herring Top 100 North America Award.

Leadership team

Ms. Shelley B. Thunen (CFO & Assistant Sec.)

Dr. Ronald M. Kurtz M.D. (Pres, CEO & Director)

Dr. Ilya Goldshleger Ph.D. (Chief Operating Officer)

Products/ Services
Biotechnology, Eyewear, Health Care, Medical Device
Number of Employees
100 - 500
Aliso Viejo, California, United States
Company Registration
SEC CIK number: 0001111485
20M - 100M
Traded as
Social Media
Fri Feb 23 2024

businessabc offers a global business, SMEs wiki directory blockchain, NFTs, AI powered marketplace for businesses worldwide.

Follow Us
Produced by
In collaboration with

Copyright 2023 © businessabc powered by ztudium